Benzinga | May 7, 2021 07:03AM EDT

Anavex Life Sciences Announces Participation At Precision In Clinical Trials Virtual Summit

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, Parkinson's disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, will give a presentation titled, "Clinical Trials for Rare Diseases: Challenges and Opportunities", at the Precision in Clinical Trials Virtual Summit (East Coast) on Monday, May 10th at 9:35 a.m. EDT. The Precision in Clinical Trials Virtual Summit (East Coast) takes place May 10th - 11th 2021.